Zhang Liyong, Anglesio Michael S, O'Sullivan Maureen, Zhang Fan, Yang Ge, Sarao Renu, Mai P Nghiem, Cronin Shane, Hara Hiromitsu, Melnyk Nataliya, Li Liheng, Wada Teiji, Liu Peter P, Farrar Jason, Arceci Robert J, Sorensen Poul H, Penninger Josef M
Institute of Molecular Biotechnology of the Austrian Academy of Sciences, Dr. Bohrgasse 3, 1030 Vienna, Austria.
Nat Med. 2007 Sep;13(9):1060-9. doi: 10.1038/nm1621. Epub 2007 Aug 12.
Transformation and cancer growth are regulated by the coordinate actions of oncogenes and tumor suppressors. Here, we show that the novel E3 ubiquitin ligase HACE1 is frequently downregulated in human tumors and maps to a region of chromosome 6q21 implicated in multiple human cancers. Genetic inactivation of HACE1 in mice results in the development of spontaneous, late-onset cancer. A second hit from either environmental triggers or genetic heterozygosity of another tumor suppressor, p53, markedly increased tumor incidence in a Hace1-deficient background. Re-expression of HACE1 in human tumor cells directly abrogates in vitro and in vivo tumor growth, whereas downregulation of HACE1 via siRNA allows non-tumorigenic human cells to form tumors in vivo. Mechanistically, the tumor-suppressor function of HACE1 is dependent on its E3 ligase activity and HACE1 controls adhesion-dependent growth and cell cycle progression during cell stress through degradation of cyclin D1. Thus, HACE1 is a candidate chromosome 6q21 tumor-suppressor gene involved in multiple cancers.
转化和肿瘤生长受癌基因与肿瘤抑制基因的协同作用调控。在此,我们表明新型E3泛素连接酶HACE1在人类肿瘤中常被下调,且定位于6号染色体6q21区域,该区域与多种人类癌症相关。小鼠中HACE1的基因失活导致自发性、迟发性癌症的发生。环境触发因素或另一种肿瘤抑制基因p53的遗传杂合性所导致的第二次打击,在Hace1缺陷背景下显著增加了肿瘤发生率。在人类肿瘤细胞中重新表达HACE1可直接消除体外和体内的肿瘤生长,而通过小干扰RNA下调HACE1则使非致瘤性人类细胞在体内形成肿瘤。从机制上讲,HACE1的肿瘤抑制功能依赖于其E3连接酶活性,并且HACE1在细胞应激期间通过降解细胞周期蛋白D1来控制黏附依赖性生长和细胞周期进程。因此,HACE1是一个参与多种癌症的6号染色体6q21候选肿瘤抑制基因。